Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Radiat Prot Dosimetry ; 168(1): 61-71, 2016 Jan.
Article in English | MEDLINE | ID: mdl-25669653

ABSTRACT

Since diagnostic reference levels (DRLs) for children are not currently established in Japan, the authors determined local DRLs for the full range of paediatric CT examinations in a single tertiary care children's hospital. A retrospective review of 4801 CT performance records for paediatric patients (<15 y old) who had undergone CT examinations from 2008 to 2011 was conducted. The most frequent examinations were of the head (52 %), followed by cardiac (15 %), temporal bone (9 %), abdomen (7 %), chest (6 %) and others (11 %). Approximately one-third of children received two or more CT scans. The authors' investigation showed that mean CTDIvol and DLP for head, chest and abdomen increased as a function of age. Benchmarking of the results showed that CTDIvol, DLP and effective dose for chest and abdomen examinations in this hospital were below average, whereas those for the head tended to be at or slightly above average of established DRL values from five countries. The results suggest that CT examinations as performed in a tertiary children's hospital in Japan are well optimised.


Subject(s)
Pediatrics , Tomography, X-Ray Computed/standards , Adolescent , Child , Child, Preschool , Female , Hospitals, Pediatric , Humans , Infant , Japan , Male , Radiation Dosage , Radiometry , Reference Values , Retrospective Studies , Tertiary Care Centers
2.
Radiat Res ; 180(4): 376-88, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23971516

ABSTRACT

Cancer of the prostate is a highly prevalent disease with a heterogeneous aetiology and prognosis. Current understanding of the biological mechanisms underlying the responses of prostate tissue to ionizing radiation exposure, including cancer induction, is surprisingly limited for both high- and low-dose exposures. As population exposure to radiation increases, largely through medical imaging, a better understanding of the response of the prostate to radiation exposure is required. Low-dose radiation-induced adaptive responses for increased cancer latency and decreased cancer frequency have been demonstrated in mouse models, largely for hematological cancers. This study examines the effects of high- and low-dose whole-body radiation exposure on prostate cancer development using an autochthonous mouse model of prostate cancer: TRansgenic Adenocarcinoma of the Mouse Prostate (TRAMP). TRAMP mice were exposed to single acute high (2 Gy), low (50 mGy) and repeated low (5 × 50 mGy) doses of X rays to evaluate both the potential prostate cancer promoting effects of high-dose radiation and low-dose adaptive response phenomena in this prostate cancer model. Prostate weights and histopathology were examined to evaluate gross changes in cancer development and, in mice exposed to a single 2 Gy dose, time to palpable tumor was examined. Proliferation (Ki-67), apoptosis, DNA damage (γ-H2AX) and transgene expression (large T-antigen) were examined within TRAMP prostate sections. Neither high- nor low-dose radiation-induced effects on prostate cancer progression were observed for any of the endpoints studied. Lack of observable effects of high- or low-dose radiation exposure suggests that modulation of tumorigenesis in the TRAMP model is largely resistant to such exposures. However, further study is required to better assess the effects of radiation exposure using alternative prostate cancer models that incorporate normal prostate and in those that are not driven by SV40 large T antigen.


Subject(s)
Adenocarcinoma/pathology , Carcinogenesis/radiation effects , Prostatic Neoplasms/pathology , Radiation Tolerance , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Animals , Antigens, Viral, Tumor/metabolism , Disease Models, Animal , Disease Progression , Dose-Response Relationship, Radiation , Female , Histones/metabolism , Ki-67 Antigen/metabolism , Male , Mice , Mice, Transgenic , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , Whole-Body Irradiation
3.
Transgenic Res ; 22(5): 1037-47, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23423848

ABSTRACT

The TRAMP (Transgenic Adenocarcinoma of the Mouse Prostate) and LADY (Probasin-large T antigen transgenic mouse) mice are widely used autochthonous models of prostate cancer. Both models utilise probasin promoters to direct androgen-regulated expression of oncogenic SV40 specifically to epithelial cells of the mouse prostate. The oncogenic processes and phenotypes which result mimic many features of human prostate cancer, making these transgenic mouse models useful experimental systems. The terminal deoxynucleotidyl transferase (Tdt)-mediated dUTP in situ nick end labelling (TUNEL) assay is a commonly used method for the detection of cells undergoing apoptosis. In this study, we demonstrate false-positive TUNEL staining in frozen prostate tissue from TRAMP and LADY mice, which was not observed in non-transgenic control animals and is not due to non-specific binding of labelled-dUTP substrate. The false-positive signal co-localised with large SV40 T-antigen expression. False-positive signal was apparent using multiple commercial TUNEL kits with different detection systems. These results caution against the use of the TUNEL assay for detection of apoptosis in frozen prostate tissue of large T-antigen based autochthonous transgenic models of prostate cancer.


Subject(s)
Disease Models, Animal , In Situ Nick-End Labeling/methods , Prostatic Neoplasms/metabolism , Androgen-Binding Protein/genetics , Animals , Antigens, Polyomavirus Transforming/metabolism , Caspase 3/metabolism , Cryopreservation , False Positive Reactions , Fluorescence , Histones/metabolism , Immunohistochemistry , Male , Mice , Mice, Transgenic , Receptors, Tumor Necrosis Factor, Member 25/genetics
4.
Am J Physiol Regul Integr Comp Physiol ; 278(3): R684-91, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10712289

ABSTRACT

Virgin, ovariectomized rats exposed to 2 wk of sequential estradiol (E(2)) and progesterone (P) followed by P withdrawal have increased hypothalamic oxytocin (OT) mRNA and peptide levels relative to sham-treated animals. This increase is prevented if P is sustained. In the central nervous system, P is metabolized to the neurosteroid allopregnanolone (3alpha-hydroxy-5alpha-pregnan-20-one), which exerts effects by acting as a positive allosteric modulator of GABA(A) receptor/Cl(-)-channel complexes. In the present study, ovariectomized rats that received sequential E(2) and P for 2 wk followed by P withdrawal were administered allopregnanolone at the time of P withdrawal. Hypothalamic and plasma allopregnanolone concentrations, serum E(2) and P concentrations, and hypothalamic OT mRNA levels were measured at death. Steroid-induced increases in OT mRNA were attenuated in animals treated with allopregnanolone at the time of P withdrawal. The results suggest that allopregnanolone plays an important modulatory role in steroid-mediated increases in hypothalamic OT.


Subject(s)
Hypothalamus/metabolism , Oxytocin/biosynthesis , Pregnanolone/metabolism , Progesterone/metabolism , Animals , Estradiol/metabolism , Estradiol/pharmacology , Female , Ovariectomy , Progesterone/pharmacology , Rats
5.
Life Sci ; 60(26): 2427-33, 1997.
Article in English | MEDLINE | ID: mdl-9199487

ABSTRACT

The nonapeptide oxytocin (OT) is important for uterine contractility at parturition, milk ejection during lactation, and the induction of maternal behavior. OT messenger ribonucleic acid (mRNA) levels increase in the paraventricular and supraoptic nuclei (PVN and SON) of late pregnant and lactating rats and are modulated by the steroid milieu that accompanies these states. Specifically, sequential exposure to estradiol (E2) and progesterone (P) followed by P withdrawal 48 hrs prior to sacrifice increases PVN, and to a lesser but significant degree, SON OT mRNA. To better define the time course of induction of OT mRNA levels following P withdrawal, ovariectomized Sprague-Dawley rats were treated with empty or steroid-filled capsules. On day 1, animals received an E2-filled or empty capsule, followed by P-filled or empty capsules on day 3. On day 14, P-filled or empty capsules were removed and animals were sacrificed 24, 36, or 48 hrs later. The hypothalamic PVN were analyzed for OT mRNA by in situ hybridization histochemistry. Significant differences in PVN OT mRNA were found among the groups (P<0.0001, Kruskal-Wallis). Animals in the 48 hr (P=0.007) and 36 hr (P=0.005), but not the 24 hr, steroid-treated groups had significantly increased OT mRNA relative to their respective sham-treated cohorts (Mann-Whitney U test). The relative abundance of PVN OT mRNA differed among the steroid-treated groups (Kruskal-Wallis, P<0.0003), with highest levels at 48 hr. We conclude that increases in PVN OT mRNA occur by 36 hrs, and are highest at 48 hrs, after P withdrawal in the E2-primed rat. Future studies will determine if OT-mediated changes in behavior or physiology that surround parturition are related to these changes in OT mRNA.


Subject(s)
Hypothalamus/drug effects , Oxytocin/metabolism , Paraventricular Hypothalamic Nucleus/drug effects , Steroids/pharmacology , Animals , Estrogens/administration & dosage , Estrogens/pharmacology , Female , Hypothalamus/metabolism , Ovariectomy , Paraventricular Hypothalamic Nucleus/metabolism , Pregnancy , Progesterone/administration & dosage , Progesterone/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Steroids/administration & dosage , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL